About Us

Coliseum's First Minimally Invasive Cardiac Procedure Performed

March 15, 2010

Coliseum Medical Centers announced the completion of its first procedure with Abiomed’s Impella 2.5 heart pump for commercial use. Now, cardiologists from Coliseum Medical Centers can add the world’s smallest heart pump to their portfolio of treatment options to assist critically ill patients that are experiencing advanced cardiac failure or shock in recovering from heart attack or other insult/injury.

In June 2008, the Impella 2.5 catheter-based heart pump received 510(k) clearance by the Food and Drug Administration. As the smallest heart pump on the market, Impella 2.5 works by temporarily relieving the heart’s pumping function and providing the time needed to initiate life-saving interventions.

Impella 2.5 is inserted percutaneously in the catheterization laboratory (cath lab) via the femoral artery into the left ventricle, a procedure that lasts just a few minutes. Up to two and a half liters of blood are delivered by the pump from the left ventricle into the ascending aorta, providing the heart with active support five times faster than current industry devices and three to five times more blood flow than the present standard of care.

With more than 700 U.S. hospitals currently using Impella 2.5, Coliseum Medical Centers adds to the growing number of healthcare institutions that are committed to optimal heart recovery and understand the importance in enabling patients to return home with their native hearts.

“Our team can now perform cutting-edge, life-saving cardiovascular procedures in a matter of minutes,” said Juan Esnard, M.D., with Coliseum Medical Centers. “Impella 2.5 is a breakthrough technology that offers our physicians a minimally invasive approach in cardiac treatment and will help change the industry standard of care in the cath lab with its seamless and immediate circulatory support for critical patients.”

About the Impella 2.5
Abiomed’s Impella 2.5 is a cardiac assist device which is inserted percutaneously in the cardiac catheterization lab, providing patients with up to 2.5 liters of blood flow per minute. It is the world's smallest heart pump and has been used to treat conditions such as acute myocardial infarction (heart attack), cardiogenic shock and low output syndrome. Due to a rise in conditions such as triple vessel disease in patients with poor cardiac function, which is caused by coronary vessel blocks in three vessels of the heart, the Impella 2.5 provides a new treatment option that aims to improve patient outcomes. The Impella 2.5 can be quickly inserted into the left ventricle through the femoral artery, into the ascending aorta, across the valve and into the left ventricle and can remain in place for short-term support. Now being used in over 500 hospitals in the U.S., the Impella 2.5 is approved in more than 40 countries, including in Europe under the CE Mark. The Impella platform has been used to treat more than 1,900 patients outside the U.S. and has been the subject of more than 50 peer reviewed publications. 

About Coliseum Medical Centers
Owned by Hospital Corporation of America (HCA), Coliseum Medical Centers is a 250 bed medical/surgical facility, with a 60 bed psychiatric facility on campus. The hospital features an expansive range of state-of-the-art services designed to meet the comprehensive medical needs of central Georgia. It includes a 24-hour emergency room, inpatient and outpatient surgery options, rehabilitation programs, and diagnostic services. Part of Coliseum Health System’s network of facilities in Macon, Coliseum Medical Centers offers specialty programs such as the Coliseum Heart Institute, an advanced cardiac center offering all services from non-invasive cardiology to open heart surgery, Coliseum Cancer Center, Coliseum Diabetes Management Center, Coliseum Wound Healing and Hyperbaric Medicine Center, and the Family Ties Birthing Center, which includes a level III neonatal nursery.

About Abiomed
Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com.

Tags: